Skip to main content
Top
Published in: BMC Public Health 1/2010

Open Access 01-12-2010 | Research article

Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening

Authors: Willi Oberaigner, Wolfgang Buchberger, Thomas Frede, Rudolf Knapp, Christian Marth, Uwe Siebert

Published in: BMC Public Health | Issue 1/2010

Login to get access

Abstract

Background

The aim of this study was to analyse breast cancer incidence and mortality in Tyrol from 1970 to 2006, namely after performing more than a decade of opportunistic mammography screening and just before piloting an organised screening programme. Our investigation was conducted on a population level.

Methods

To study time trends in breast cancer incidence and mortality, we applied the age-period-cohort model by Poisson regression to the official mortality data covering more than three decades from 1970 to 2006 and to the incidence data ranging from 1988 to 2006. In addition, for incidence data we analysed data on breast cancer staging and compared these with EU guidelines.

Results

For the analysis of time trend in breast cancer mortality in age groups 40-79, an age-period-cohort model fits well and shows for years 2002-2006 a statistically significant reduction of 26% (95% CI 13%-36%) in breast cancer mortality as compared to 1992-1996.
We see only slight non-significant increases in breast cancer incidence. For the past five years, incidence data show a 10% proportion of in situ cases, and of 50% for cases in stages II+.

Conclusions

The opportunistic breast cancer screening programme in Tyrol has only in part exploited the mortality reduction known for organised screening programmes. There seems to be potential for further improvement, and we recommend that an organised screening programme and a detailed screening database be introduced to collect all information needed to analyse the quality indicators suggested by the EU guidelines.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.CrossRefPubMed
2.
go back to reference Perry N, Broeders M, de Wolf C, (eds), et al: European guidelines for quality assurance in breast cancer screening and diagnosis. 2006, Luxembourg: Office for Official Publication of the European Communities, Fourth Perry N, Broeders M, de Wolf C, (eds), et al: European guidelines for quality assurance in breast cancer screening and diagnosis. 2006, Luxembourg: Office for Official Publication of the European Communities, Fourth
3.
go back to reference Österr. Gesundheitsbefragung 2006/07. 2008, Wien: Statistik Österreich, (In German: Health Survey in Austria 2006/07) Österr. Gesundheitsbefragung 2006/07. 2008, Wien: Statistik Österreich, (In German: Health Survey in Austria 2006/07)
4.
go back to reference Cronin KA, Miglioretti DL, Krapcho M, Yu B, Geller BM, Carney PA, et al: Bias associated with self-report of prior screening mammography. Cancer Epid Biom Prev. 2009, 18 (6): 1699-705. 10.1158/1055-9965.EPI-09-0020.CrossRef Cronin KA, Miglioretti DL, Krapcho M, Yu B, Geller BM, Carney PA, et al: Bias associated with self-report of prior screening mammography. Cancer Epid Biom Prev. 2009, 18 (6): 1699-705. 10.1158/1055-9965.EPI-09-0020.CrossRef
5.
go back to reference Frede TE: Opportunistic breast cancer early detection in Tyrol, Austria 1996-2004. Is a mammography-screening program necessary?. Eur J Radiol. 2005, 55 (1): 130-8. 10.1016/j.ejrad.2005.04.019.CrossRefPubMed Frede TE: Opportunistic breast cancer early detection in Tyrol, Austria 1996-2004. Is a mammography-screening program necessary?. Eur J Radiol. 2005, 55 (1): 130-8. 10.1016/j.ejrad.2005.04.019.CrossRefPubMed
6.
go back to reference Vutuc C, Waldhoer T, Haidinger G: Breast cancer trends: opportunistic screening in Austria versus controlled screening in Finland and Sweden. Eur J Cancer Prev. 2006, 15 (4): 343-6. 10.1097/00008469-200608000-00007.CrossRefPubMed Vutuc C, Waldhoer T, Haidinger G: Breast cancer trends: opportunistic screening in Austria versus controlled screening in Finland and Sweden. Eur J Cancer Prev. 2006, 15 (4): 343-6. 10.1097/00008469-200608000-00007.CrossRefPubMed
7.
go back to reference Oberaigner W, Mühlböck H, Harrasser L: Tumorregister Tirol Bericht für die Diagnosejahre 2004/2006. 2008, Innsbruck: IET-Bericht, (In German) Oberaigner W, Mühlböck H, Harrasser L: Tumorregister Tirol Bericht für die Diagnosejahre 2004/2006. 2008, Innsbruck: IET-Bericht, (In German)
8.
go back to reference Leitner B: Qualitätsaspekte der Todesursachenstatistik. Statist Nachrichten. 2005, 9: 790-7. (In German) Leitner B: Qualitätsaspekte der Todesursachenstatistik. Statist Nachrichten. 2005, 9: 790-7. (In German)
9.
go back to reference Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas B: Cancer Incidence in Five Continents. Volume VIII. 2002, Lyon: IARC Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas B: Cancer Incidence in Five Continents. Volume VIII. 2002, Lyon: IARC
10.
go back to reference Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue J, Boyle P: Cancer Incidence in Five Continents. 2007, (IARC Scientific Publications No. 160). Lyon: IARC, IX: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue J, Boyle P: Cancer Incidence in Five Continents. 2007, (IARC Scientific Publications No. 160). Lyon: IARC, IX:
11.
go back to reference Clayton D, Schifflers E: Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med. 1987, 6 (4): 449-67. 10.1002/sim.4780060405.CrossRefPubMed Clayton D, Schifflers E: Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med. 1987, 6 (4): 449-67. 10.1002/sim.4780060405.CrossRefPubMed
12.
go back to reference Clayton D, Schifflers E: Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med. 1987, 6 (4): 469-81. 10.1002/sim.4780060406.CrossRefPubMed Clayton D, Schifflers E: Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med. 1987, 6 (4): 469-81. 10.1002/sim.4780060406.CrossRefPubMed
13.
go back to reference Stata Statistical Software. 2005, Release 9.0. College Station, TX: StataCorp LP Stata Statistical Software. 2005, Release 9.0. College Station, TX: StataCorp LP
15.
go back to reference Oberaigner W, Siebert U: Are survival rates for Tyrol published in the Eurocare studies biased?. Act Oncol. 2009, 48 (7): 984-91. 10.1080/02841860903188635.CrossRef Oberaigner W, Siebert U: Are survival rates for Tyrol published in the Eurocare studies biased?. Act Oncol. 2009, 48 (7): 984-91. 10.1080/02841860903188635.CrossRef
16.
go back to reference Baré ML, Montes J, Florensa F, Sentís M, Donoso L: Factors related to non-participation in a population-based breast cancer screening programme. Eur J Cancer Prev. 2003, 12 (6): 487-94. 10.1097/00008469-200312000-00007.CrossRefPubMed Baré ML, Montes J, Florensa F, Sentís M, Donoso L: Factors related to non-participation in a population-based breast cancer screening programme. Eur J Cancer Prev. 2003, 12 (6): 487-94. 10.1097/00008469-200312000-00007.CrossRefPubMed
17.
go back to reference Bray F, Moller B: Predicting the future burden of cancer. Nat Rev Cancer. 2006, 6 (1): 63-74. 10.1038/nrc1781.CrossRefPubMed Bray F, Moller B: Predicting the future burden of cancer. Nat Rev Cancer. 2006, 6 (1): 63-74. 10.1038/nrc1781.CrossRefPubMed
18.
go back to reference Holford TR: Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health. 1991, 12: 425-57. 10.1146/annurev.pu.12.050191.002233.CrossRefPubMed Holford TR: Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health. 1991, 12: 425-57. 10.1146/annurev.pu.12.050191.002233.CrossRefPubMed
19.
go back to reference Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al: The Decrease in Breast-Cancer Incidence in 2003 in the United States. NEM. 2007, 356 (16): 1670-4. 10.1056/NEJMsr070105.CrossRef Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al: The Decrease in Breast-Cancer Incidence in 2003 in the United States. NEM. 2007, 356 (16): 1670-4. 10.1056/NEJMsr070105.CrossRef
20.
go back to reference IARC Handbooks of Cancer Prevention: Breast Cancer Screening. 2002, Lyon: IARC-Publications, 7: IARC Handbooks of Cancer Prevention: Breast Cancer Screening. 2002, Lyon: IARC-Publications, 7:
21.
go back to reference Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ: Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ. 2000, 321 (7262): 665-9. 10.1136/bmj.321.7262.665.CrossRefPubMedPubMedCentral Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ: Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ. 2000, 321 (7262): 665-9. 10.1136/bmj.321.7262.665.CrossRefPubMedPubMedCentral
22.
go back to reference Otto SJ, Fracheboud J, Looman CWN, Broeders MJM, Boer R, Hendriks JHCL, et al: Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality. A systematic review. Lancet. 2003, 361: 1411-17. 10.1016/S0140-6736(03)13132-7.CrossRefPubMed Otto SJ, Fracheboud J, Looman CWN, Broeders MJM, Boer R, Hendriks JHCL, et al: Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality. A systematic review. Lancet. 2003, 361: 1411-17. 10.1016/S0140-6736(03)13132-7.CrossRefPubMed
23.
go back to reference Jonsson H, Nyström L, Törnberg S, Lenner P: Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen. 2001, 8: 152-60. 10.1136/jms.8.3.152.CrossRefPubMed Jonsson H, Nyström L, Törnberg S, Lenner P: Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen. 2001, 8: 152-60. 10.1136/jms.8.3.152.CrossRefPubMed
24.
go back to reference Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, et al: The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer. 2002, 95: 458-69. 10.1002/cncr.10765.CrossRefPubMed Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, et al: The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer. 2002, 95: 458-69. 10.1002/cncr.10765.CrossRefPubMed
25.
go back to reference Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE: Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002, 359: 909-19. 10.1016/S0140-6736(02)08020-0.CrossRefPubMed Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE: Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002, 359: 909-19. 10.1016/S0140-6736(02)08020-0.CrossRefPubMed
26.
go back to reference Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, et al: Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ. 2005, 330 (7485): 220-10.1136/bmj.38313.639236.82.CrossRefPubMedPubMedCentral Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, et al: Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ. 2005, 330 (7485): 220-10.1136/bmj.38313.639236.82.CrossRefPubMedPubMedCentral
27.
go back to reference Gotzsche PC, Nielsen M: Screening for Breast cancer with Mammography. Cochrane Database of Systematic Reviews. 2006, CD001877-4 Gotzsche PC, Nielsen M: Screening for Breast cancer with Mammography. Cochrane Database of Systematic Reviews. 2006, CD001877-4
28.
go back to reference Anttila A, Koskela J, Hakama M: Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen. 2002, 9 (4): 153-8. 10.1136/jms.9.4.153.CrossRefPubMed Anttila A, Koskela J, Hakama M: Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen. 2002, 9 (4): 153-8. 10.1136/jms.9.4.153.CrossRefPubMed
29.
go back to reference Blanks RG, Moss SM, Patnick J: Results from the UK NHS breast screening programme 1994-1999. J Med Screen. 2000, 7 (4): 195-8. 10.1136/jms.7.4.195.CrossRefPubMed Blanks RG, Moss SM, Patnick J: Results from the UK NHS breast screening programme 1994-1999. J Med Screen. 2000, 7 (4): 195-8. 10.1136/jms.7.4.195.CrossRefPubMed
30.
go back to reference Hakama M, Pukkala E, Heikkila M, Kallio M: Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ. 1997, 314 (7084): 864-7.CrossRefPubMedPubMedCentral Hakama M, Pukkala E, Heikkila M, Kallio M: Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ. 1997, 314 (7084): 864-7.CrossRefPubMedPubMedCentral
31.
go back to reference The Swedish Organised Service Screening Evaluation Group: Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 1. Further Confirmation with Extended Data. Cancer Epidem Bio Prev. 2006, 15 (1): 45-51. 10.1158/1055-9965.EPI-05-0349.CrossRef The Swedish Organised Service Screening Evaluation Group: Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 1. Further Confirmation with Extended Data. Cancer Epidem Bio Prev. 2006, 15 (1): 45-51. 10.1158/1055-9965.EPI-05-0349.CrossRef
32.
go back to reference Törnberg S, Carstensen J, Hakulinen T, Lenner P, Hatschek T, Lundgren B: Evaluation of the effect on breast cancer mortality of population based mammography screening programmes. J Med Screen. 1994, 1: 184-7.PubMed Törnberg S, Carstensen J, Hakulinen T, Lenner P, Hatschek T, Lundgren B: Evaluation of the effect on breast cancer mortality of population based mammography screening programmes. J Med Screen. 1994, 1: 184-7.PubMed
33.
go back to reference Peto R, Boreham J, Clarke M, Davies C, Beral V: UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet. 2000, 355 (9217): 1822-10.1016/S0140-6736(00)02277-7.CrossRefPubMed Peto R, Boreham J, Clarke M, Davies C, Beral V: UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet. 2000, 355 (9217): 1822-10.1016/S0140-6736(00)02277-7.CrossRefPubMed
34.
go back to reference Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al: Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer. NEJM. 2005, 353 (17): 1784-92. 10.1056/NEJMoa050518.CrossRefPubMed Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al: Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer. NEJM. 2005, 353 (17): 1784-92. 10.1056/NEJMoa050518.CrossRefPubMed
35.
go back to reference Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, Vezzosi V, et al: Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. Br J Cancer. 2002, 87 (1): 65-9. 10.1038/sj.bjc.6600301.CrossRefPubMedPubMedCentral Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, Vezzosi V, et al: Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. Br J Cancer. 2002, 87 (1): 65-9. 10.1038/sj.bjc.6600301.CrossRefPubMedPubMedCentral
36.
go back to reference Baker S, Wall M, Bloomfield A: Breast cancer screening for women aged 40 to 49 years--what does the evidence mean for New Zealand?. N Z Med J. 2005, 118 (1221): U1628-PubMed Baker S, Wall M, Bloomfield A: Breast cancer screening for women aged 40 to 49 years--what does the evidence mean for New Zealand?. N Z Med J. 2005, 118 (1221): U1628-PubMed
37.
go back to reference Kolb TM, Lichy J, Newhouse JH: Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002, 225 (1): 165-75. 10.1148/radiol.2251011667.CrossRefPubMed Kolb TM, Lichy J, Newhouse JH: Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002, 225 (1): 165-75. 10.1148/radiol.2251011667.CrossRefPubMed
38.
go back to reference Nothacker M, Duda V, Hahn M, Warm M, Degenhardt F, Madjar H, Weinbrenner S, Albert US: Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review. BMC Cancer. 2009, 9: 335-10.1186/1471-2407-9-335.CrossRefPubMedPubMedCentral Nothacker M, Duda V, Hahn M, Warm M, Degenhardt F, Madjar H, Weinbrenner S, Albert US: Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review. BMC Cancer. 2009, 9: 335-10.1186/1471-2407-9-335.CrossRefPubMedPubMedCentral
39.
go back to reference Buchberger W, Niehoff A, Obrist P, DeKoekkoek-Doll P, Dunser M: Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. Semin Ultrasound CT MR. 2000, 21 (4): 325-36. 10.1016/S0887-2171(00)90027-1.CrossRefPubMed Buchberger W, Niehoff A, Obrist P, DeKoekkoek-Doll P, Dunser M: Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. Semin Ultrasound CT MR. 2000, 21 (4): 325-36. 10.1016/S0887-2171(00)90027-1.CrossRefPubMed
40.
go back to reference Mandelblatt JS, Cronin KA, Bailey S, et al: Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009, 151 (10): 738-47.CrossRefPubMedPubMedCentral Mandelblatt JS, Cronin KA, Bailey S, et al: Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009, 151 (10): 738-47.CrossRefPubMedPubMedCentral
41.
go back to reference Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009, 151 (10): 716-26. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009, 151 (10): 716-26.
Metadata
Title
Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening
Authors
Willi Oberaigner
Wolfgang Buchberger
Thomas Frede
Rudolf Knapp
Christian Marth
Uwe Siebert
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2010
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-10-86

Other articles of this Issue 1/2010

BMC Public Health 1/2010 Go to the issue